Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy

Clinical trial NCT03013946 · TERMINATED

Trial details

NCT number

NCT03013946

Sponsor

AIO-Studien-gGmbH

Status

TERMINATED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2017-01-18

Primary completion

2024-01-16

Enrollment

121

View on ClinicalTrials.gov